ACTUM I, LLC

Lobbying for PRIO PHARMA, INC. · pharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $10,000.00 income · posted Apr 20, 2025

Lobbying activity 2

Budget/Appropriations

Defense Health Program funding; FY25 Continuing Resolution (P.L. 119-4)

Defense

Defense Health Program funding.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.